Moomoo AI 已提取核心訊息
On December 31, 2023, Intelligent Bio Solutions Inc. was the subject of a Schedule 13G filing with the SEC, indicating changes in ownership by several related entities and individuals. Bigger Capital Fund, LP, along with its general partner Bigger Capital Fund GP, LLC, and several associated entities including District 2 Capital Fund LP, District 2 Capital LP, District 2 GP LLC, District 2 Holdings LLC, and individual Michael Bigger, reported ownership of warrants to purchase shares of Intelligent Bio Solutions. The warrants held by each entity and Michael Bigger individually allow for the purchase of 75,758 shares, except for Michael Bigger who holds warrants for 151,516 shares. Collectively, these holdings represent less than one percent of the company's class of securities for each reporting entity, with Michael Bigger's stake amounting to approximately 1.7%. The filing, dated February 5, 2024, asserts that the securities were not acquired for the purpose of changing or influencing the control of Intelligent Bio Solutions Inc. and were not held in connection with any transaction having that purpose or effect.
On December 31, 2023, Intelligent Bio Solutions Inc. was the subject of a Schedule 13G filing with the SEC, indicating changes in ownership by several related entities and individuals. Bigger Capital Fund, LP, along with its general partner Bigger Capital Fund GP, LLC, and several associated entities including District 2 Capital Fund LP, District 2 Capital LP, District 2 GP LLC, District 2 Holdings LLC, and individual Michael Bigger, reported ownership of warrants to purchase shares of Intelligent Bio Solutions. The warrants held by each entity and Michael Bigger individually allow for the purchase of 75,758 shares, except for Michael Bigger who holds warrants for 151,516 shares. Collectively, these holdings represent less than one percent of the company's class of securities for each reporting entity, with Michael Bigger's stake amounting to approximately 1.7%. The filing, dated February 5, 2024, asserts that the securities were not acquired for the purpose of changing or influencing the control of Intelligent Bio Solutions Inc. and were not held in connection with any transaction having that purpose or effect.
2023年12月31日，Intelligent Bio Solutions Inc.成爲向美國證券交易委員會提交的附表13G文件的主體，該文件顯示多個關聯實體和個人的所有權發生了變化。Bigger Capital Fund, LP及其普通合夥人Bigger Capital Fund GP, LLC以及包括第二區資本基金有限責任公司、第二區資本有限責任公司、第二區GP LLC、第二區控股有限責任公司和個人邁克爾·比格在內的幾家關聯實體報告了購買智能生物解決方案股份的認股權證的所有權。每個實體和邁克爾·比格單獨持有的認股權證允許購買75,758股股票，但邁克爾·比格除外，他持有151,516股認股...展開全部
2023年12月31日，Intelligent Bio Solutions Inc.成爲向美國證券交易委員會提交的附表13G文件的主體，該文件顯示多個關聯實體和個人的所有權發生了變化。Bigger Capital Fund, LP及其普通合夥人Bigger Capital Fund GP, LLC以及包括第二區資本基金有限責任公司、第二區資本有限責任公司、第二區GP LLC、第二區控股有限責任公司和個人邁克爾·比格在內的幾家關聯實體報告了購買智能生物解決方案股份的認股權證的所有權。每個實體和邁克爾·比格單獨持有的認股權證允許購買75,758股股票，但邁克爾·比格除外，他持有151,516股認股權證。總的來說，這些持股量佔公司每個申報實體證券類別的不到百分之一，邁克爾·比格的股份約爲1.7％。這份日期爲2024年2月5日的文件稱，收購這些證券不是爲了改變或影響Intelligent Bio Solutions Inc.的控制權，也不是與任何具有該目的或效果的交易有關而持有的。
有用
沒用